What Comes Next? Strategies for COVID-19 Vaccine Development

View Calendar
2020-05-27 8:00 pm - 10:00 pm

What Comes Next? Strategies for COVID-19 Vaccine Development

It has been more than a hundred days since Chinese researchers posted the genetic sequence for the SARS-CoV2 virus to a public database, setting off the biggest and fastest race to create vaccines the world has ever seen. One of the defining features of the race is diversity -- of vaccine modalities, types of organizations developing them, and geographic distribution of R&D and manufacturing. So far, at least six vaccines have made it into the clinic. We have reached the end of the beginning: What comes next?

In this exclusive webinar, BioCentury, BioKatalyst and Lonza bring together industry and policy leaders to discuss how to accelerate COVID-19 vaccine development.

Webinar Registration

Session Chair

Steve Usdin - Washington Editor、BioCentury


  • William “Bill” Enright - Director and CEO | Vaccitech, Ltd.

  • Nicole Lurie, M.D., M.S.P.H.: Strategic Advisor, CEPI (The Coalition for Epidemic Preparedness Innovation); and former Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services

  • Xuefeng YU, Ph.D : Co-founder, Chairman and CEO | CanSino Biologics Inc.